Reduction of Topical Anesthetic Time for Subcutaneous Port Access Using Ultrasound

Phase 4

Completed

• Conditions: Pain

• Registration Number: NCT00126919
• Lead Sponsor: Connecticut Children's Medical Center

Brief Summary

Children ages 3-17 who are undergoing port access receive both standard care, topical medicine for numbing (LMX4), and the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The procedures will be performed on 2 separate visits to the clinic. The child's pain with the access procedure is evaluated.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-10
• Study First Submitted: 2005-08-03
• Study First Submitted QC: 2005-08-03
• Study First Posted: 2005-08-05
• Primary Completion: 2006-10
• Study Completion: 2006-10
• Status Verified: 2012-02
• Last Update Submitted: 2012-02-08
• Last Update Posted: 2012-02-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Children ages 3-17 with subcutaneous port

Exclusion Criteria

• Emergent need for port access
• Allergy to lidocaine sodium lauryl sulfate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
pain

Secondary Outcome Measures

Name	Time	Method
safety-skin effects
tolerability

Trial Locations

Locations (1)

Connecticut Children's Medical Center; 🇺🇸 Hartford, Connecticut, United States